Mowery & Schoenfeld Wealth Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Mowery & Schoenfeld Wealth Management’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.38K	Hold	13	–	–	﹤0.01%	339
2026 Q1	$1.31K	Hold	13	–	–	﹤0.01%	331
2025 Q4	$1.3K	Hold	13	–	–	﹤0.01%	432
2025 Q3	$1.14K	Hold	13	–	–	﹤0.01%	359
2025 Q2	$1.11K	Hold	13	–	–	﹤0.01%	359
2025 Q1	$1.15K	Buy	+13	New	+$1.17K	﹤0.01%	408

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Mowery & Schoenfeld Wealth Management's PPH Position: Q2 2026 in Review

Mowery & Schoenfeld Wealth Management held its VanEck Pharmaceutical ETF (PPH) position steady in Q2 2026 at 13 shares worth $1.38K. The position accounts for ﹤0.01% of the portfolio, ranked #339.

Mowery & Schoenfeld Wealth Management first reported a position in PPH in Q1 2025 and has held it in 6 quarters since. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Mowery & Schoenfeld Wealth Management held 13 shares of VanEck Pharmaceutical ETF worth $1.38K as of Q2 2026.
Mowery & Schoenfeld Wealth Management left its VanEck Pharmaceutical ETF share count unchanged in Q2 2026.
VanEck Pharmaceutical ETF made up ﹤0.01% of Mowery & Schoenfeld Wealth Management's portfolio in Q2 2026, its #339 holding.
Mowery & Schoenfeld Wealth Management first reported a position in VanEck Pharmaceutical ETF in Q1 2025 and has held it in 6 quarters since.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Mowery & Schoenfeld Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.